From Biogen To Bayer: Coronavirus A Stress Test For Pharma

Global Meets Local Manifested By Pandemic

When a global pandemic hits and local rules over personal movement are highly fluid and constantly updated, two pharma firms with a global footprint have faced unprecedented tests.

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
VIRUS POSES CHALLENGES FOR GLOBAL PHARMA • Source: Shutterstock

More from COVID-19

More from Scrip